AbbVie Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
18,790
19,960
22,859
25,638
28,216
32,753
Cost of Goods Sold (COGS) incl. D&A
4,552
4,310
4,698
5,814
6,804
7,557
Gross Income
14,238
15,650
18,161
19,824
21,412
25,196
SG&A Expense
7,899
8,853
9,720
10,029
10,801
12,558
EBIT
6,339
6,047
8,441
9,795
10,611
12,138
Unusual Expense
577
3,081
1,360
704
1,859
5,560
Non Operating Income/Expense
152
206
250
281
21
237
Interest Expense
299
429
719
1,008
1,150
1,348
Pretax Income
5,332
2,369
6,645
7,884
7,727
5,197
Income Tax
1,204
595
1,501
1,931
2,418
490
Consolidated Net Income
4,102
1,765
5,118
5,923
5,283
5,657
Net Income
4,102
1,765
5,118
5,923
5,283
5,657
Net Income After Extraordinaries
4,102
1,765
5,118
5,923
5,283
5,657
Net Income Available to Common
4,102
1,765
5,118
5,923
5,283
5,657
EPS (Basic)
2.56
1.10
3.13
3.63
3.30
3.66
Basic Shares Outstanding
1,589
1,595
1,625
1,622
1,596
1,541
EPS (Diluted)
2.56
1.10
3.13
3.63
3.30
3.66
Diluted Shares Outstanding
1,604
1,610
1,637
1,631
1,603
1,546
EBITDA
7,236
6,833
9,277
10,984
12,112
13,903
Other Operating Expense
-
750
-
-
-
500
Non-Operating Interest Income
21
38
33
82
146
204
Other After Tax Income (Expense)
26
9
26
30
26
30

About AbbVie

View Profile
Address
1 North Waukegan Road
North Chicago Illinois 60064
United States
Employees -
Website http://www.abbvie.com
Updated 07/08/2019
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.